These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16467676)

  • 21. Intravitreal clearance of moxifloxacin.
    Iyer MN; He F; Wensel TG; Mieler WF; Benz MS; Holz ER
    Trans Am Ophthalmol Soc; 2005; 103():76-81; discussion 81-3. PubMed ID: 17057790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
    Unal M; Peyman GA
    Retina; 2000; 20(1):69-75. PubMed ID: 10696751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study.
    Macky TA; Helmy D; El Shazly N
    Graefes Arch Clin Exp Ophthalmol; 2007 Jun; 245(6):817-24. PubMed ID: 17111149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing intravitreal toxicity of rapamycin in rabbit eyes.
    Manzano RP; Peyman GA; Khan P; Kivilcim M; Chevez-Barrios P; Takahashi W
    Arq Bras Oftalmol; 2009; 72(1):18-22. PubMed ID: 19347116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes.
    Wiechens B; Neumann D; Grammer JB; Pleyer U; Hedderich J; Duncker GI
    Int Ophthalmol; 1998-1999; 22(3):133-43. PubMed ID: 10548457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P; Bakri SJ; Beer PM; Singh RJ; Falk NS; Peters GB; Melendez JA
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal docosahexaenoic acid in a rabbit model: preclinical safety assessment.
    Dolz-Marco R; Gallego-Pinazo R; Pinazo-Duran MD; Pons-Vázquez S; Domingo-Pedro JC; Díaz-Llopis M
    PLoS One; 2014; 9(5):e96872. PubMed ID: 24809445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.
    Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y; Zemel E; Miller B; Perlman I
    Retina; 2007; 27(6):778-88. PubMed ID: 17621190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of intravitreal clindamycin in albino rabbit eyes.
    Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I
    Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal toxicity of intravitreally injected faeriefungin.
    Dunlap WA; Karaçorlu M; Peyman GA; Nair MG; Rahimy M; Pedroza L
    Ophthalmic Surg; 1994 May; 25(5):303-6. PubMed ID: 8058262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%.
    Williams KK; Shepard AR; Rice RL; McCartney MD; Wax MB; Hiddemen JW
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):517-25. PubMed ID: 18001231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.
    Veckeneer M; van Overdam K; Monzer J; Kobuch K; van Marle W; Spekreijse H; van Meurs J
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):698-704. PubMed ID: 11688671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on the toxicity of intravitreal levofloxacin in rabbits.
    Gurler B; Ozkul Y; Bitiren M; Karadede S; Gurkan T
    Curr Eye Res; 2002 Apr; 24(4):253-62. PubMed ID: 12324863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal Toxicity of Intravitreal Granulocyte Colony-Stimulating Factor in Rabbit Eyes.
    Falavarjani KG; Habibi A; Pourhabibi A; Hosseini SB; Modarres M; Parvaresh MM; Shahriari-Ahmadi A
    Curr Eye Res; 2017 Apr; 42(4):636-639. PubMed ID: 27732124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal voriconazole: an electroretinographic and histopathologic study.
    Gao H; Pennesi ME; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Arch Ophthalmol; 2004 Nov; 122(11):1687-92. PubMed ID: 15534131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
    Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
    Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.